DEVELOPMENT OF TARGETED THERAPIES FOR METASTATIC PROSTATE CANCERS CLASSIFIED BY SUBTYPES OF DNA REPAIR DEFICIENCY
$1,927,373FY2025Defense Health AgencyDOD
Fred Hutchinson Cancer Center, Seattle WA
Investigators
View source on USAspending →DEVELOPMENT OF TARGETED THERAPIES FOR METASTATIC PROSTATE CANCERS CLASSIFIED BY SUBTYPES OF DNA REPAIR DEFICIENCY · GrantIndex